UPLYFT For Lymphoma Survivors

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Dana-Farber Cancer Institute
Study ID
NCT05080166
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Interview with Clinicians — OTHER
    One time, qualitative interview of clinicians for feedback on UPLYFT intervention
  • Field Test of UPLYFT with Lymphoma Survivors — OTHER
    6 session of UPLYFT intervention with Lymphoma Survivors for feedback
  • Pilot of UPLYFT with Lymphoma Survivors — BEHAVIORAL
    6 session of UPLYFT intervention with Lymphoma Survivors

Study Details

The main purpose of this study is to field test and pilot an intervention called UPLYFT (Understand and Prevail: Lymphoma Fear of Recurrence Therapy) that includes information about lymphoma survivorship and tools to improve quality of life and reduce lymphoma-related worries among lymphoma survivors.

Key Dates

Start date
Feb 8, 2022
Status verified
Feb 2026
Primary completion
May 31, 2026
Completion
Aug 31, 2026

Study Design

Enrollment
74 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Clinicians Interviews
    Lymphoma and mental health clinicians will participate in 1x in-depth qualitative interview to provide feedback for the development of the UPLYFT program.
  • Experimental: Lymphoma Survivors Field Test
    A six person group of lymphoma survivors will participate in a six session UPLYFT program field test to provide feedback for the development of the UPLYFT program.
  • Experimental: UPLYFT Pilot
    Lymphoma survivors will participate in the phase 1 finalized, six session UPLYFT program. Participants will be randomized 1:1 to either UPLYFT or usual care.

Primary Outcome Measure

Feasibility: Enrollment Rate [ Time Frame: Up to 6 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Dana-Farber Cancer InstituteBostonMassachusetts02215
Oreofe O Odejide, MD, MPH
[email protected]
617-632-6864
Oreofe O Odejide, MD, MPH (PRINCIPAL_INVESTIGATOR)

Find similar trials in Boston, MA

By research site
Dana-Farber Cancer Institute· Boston, MA

Related Studies